Inge v. McClelland

CourtCourt of Appeals for the Tenth Circuit
DecidedFebruary 20, 2018
Docket17-2109
StatusUnpublished

This text of Inge v. McClelland (Inge v. McClelland) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Inge v. McClelland, (10th Cir. 2018).

Opinion

FILED United States Court of Appeals UNITED STATES COURT OF APPEALS Tenth Circuit

FOR THE TENTH CIRCUIT February 20, 2018 _________________________________ Elisabeth A. Shumaker Clerk of Court ELIZABETH INGE, individually; JOHNNY INGE, individually,

Plaintiffs - Appellants,

v. No. 17-2109 (D.C. No. 2:16-CV-01232-JAP-KRS) ROBERT MCCLELLAND, III, (D. N.M.) individually, Tucumcari, New Mexico, a/k/a Bob McClelland, d/b/a Bob’s Budget Pharmacy,

Defendant - Appellee. _________________________________

ORDER AND JUDGMENT* _________________________________

Before MATHESON, BACHARACH, and PHILLIPS, Circuit Judges. _________________________________

Elizabeth and Johnny Inge appeal the district court’s dismissal of their claims

against Robert McClelland, III, a pharmacist licensed in New Mexico who dispensed

opioids and other narcotics to them for over a year. Exercising jurisdiction under

28 U.S.C. § 1291, we affirm.

* After examining the briefs and appellate record, this panel has determined unanimously to honor the parties’ request for a decision on the briefs without oral argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore submitted without oral argument. This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. It may be cited, however, for its persuasive value consistent with Fed. R. App. P. 32.1 and 10th Cir. R. 32.1. I. Background

According to the amended complaint, McClelland filled the Inges’

prescriptions for thousands of powerful narcotic pills while “knowing that there was

absolutely no medical necessity or benefit to prescribing these medications,” Aplt.

App. at 25, and while he “knew or should have known [they] were being abused by

[the Inges],” id. at 27. The complaint alleges that the Inges suffered numerous

injuries as a result of their abuse of these narcotics and seeks to hold McClelland

liable for violation of the Racketeer Influenced and Corrupt Organizations Act

(RICO), negligence, unfair practices, and breach of fiduciary duties.

After McClelland filed an answer, both McClelland and the Inges filed

supplemental joint status reports. Included in the Inges’ report were their “amended

contentions” that they participated in a scheme with a nurse practitioner1 who

proposed writing them prescriptions in exchange for half of the pills they received

and that McClelland filled their prescriptions “for powerful and dangerous amounts

of pain pills” while knowing the prescriptions were “bogus.” Id. at 80, 81.

Relying in part on statements from the Inges’ report, McClelland filed a

motion to dismiss. He argued that “[b]y their own admission, [the Inges] participated

in a criminal and fraudulent scheme to obtain the same prescription narcotics made

the basis of this lawsuit, which constitutes an absolute bar to their recovery pursuant

to the wrongful conduct rule.” Id. at 87.

1 The nurse practitioner is not a party to this lawsuit. According to the Inges’ report, he was investigated and criminally charged and later killed himself. 2 The district court agreed that the Inges failed to state a claim under

Fed. R. Civ. P. 12(b)(6). In making that determination, the court relied on the

allegations in the amended complaint and the “amended contentions” in the Inges’

supplemental status report. Id. at 79. The court concluded that the Inges’ recovery

against McClelland was barred due to their admitted, willful participation in the

scheme to obtain narcotics with invalid prescriptions in violation of federal and state

law. See 21 U.S.C. § 843(a)(3) (prohibiting acquiring or obtaining possession of a

controlled substance by misrepresentation, fraud, forgery, deception, or subterfuge);

N.M. Stat. Ann. § 30-31-23 (prohibiting possessing a controlled substance unless it

was obtained pursuant to a valid prescription).

II. Analysis

We review de novo the district court’s dismissal of a complaint for failure to

state a claim. “To survive a motion to dismiss, a complaint must contain sufficient

factual matter, accepted as true, to state a claim to relief that is plausible on its face.”

Pueblo of Jemez v. United States, 790 F.3d 1143, 1171 (10th Cir. 2015) (internal

quotation marks omitted); see also Fed. R. Civ. P. 8(a)(2) (requiring only “a short

and plain statement of the claim showing that the pleader is entitled to relief”). “A

claim has facial plausibility when the plaintiff pleads factual content that allows the

court to draw the reasonable inference that the defendant is liable for the misconduct

alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). “[C]omplaints that are no

more than labels and conclusions or a formulaic recitation of the elements of a cause

of action” will not meet the standard established by the Supreme Court in Bell

3 Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007), and Iqbal, 556 U.S. at 678.

Khalik v. United Air Lines, 671 F.3d 1188, 1191-92 (10th Cir. 2012) (internal

quotation marks omitted).

A. Preliminary Matters

The Inges first argue that the district erred by applying the wrongful-conduct

doctrine because McClelland waived its application by failing to raise it as an

affirmative defense in his answer. There, McClelland did assert that the Inges’

complaint failed to state a claim for which relief may be granted, and, in granting the

motion to dismiss, the district court agreed. Noting that “strict adherence to the

pleading requirement [of Fed. R. Civ. P. 8(c)] is inappropriate when the purpose of

the requirement [to safeguard against surprise and unfair prejudice] has otherwise

been fulfilled,” Aplt. App. at 126 (internal quotation marks omitted), the court

concluded that the Inges were barred from asserting their claims because those claims

were based on their own wrongful conduct.

In applying the pleading rules established by the Federal Rules of Civil

Procedure, we strive to “avoid hypertechnicality in pleading requirements and focus,

instead, on enforcing the actual purpose of the rule.” Creative Consumer Concepts,

Inc. v. Kreisler, 563 F.3d 1070, 1076 (10th Cir. 2009) (internal quotation marks

omitted). Further,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rogers v. McDorman
521 F.3d 381 (Fifth Circuit, 2008)
Pinter v. Dahl
486 U.S. 622 (Supreme Court, 1988)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Creative Consumer Concepts, Inc. v. Kreisler
563 F.3d 1070 (Tenth Circuit, 2009)
Khalik v. United Air Lines
671 F.3d 1188 (Tenth Circuit, 2012)
Orzel v. Scott Drug Co.
537 N.W.2d 208 (Michigan Supreme Court, 1995)
Desmet v. Sublett
225 P.2d 141 (New Mexico Supreme Court, 1950)
Pueblo of Jemez v. United States
790 F.3d 1143 (Tenth Circuit, 2015)
Pikk v. Pedersen
826 F.3d 1222 (Tenth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Inge v. McClelland, Counsel Stack Legal Research, https://law.counselstack.com/opinion/inge-v-mcclelland-ca10-2018.